Innovators in Discovery
W. Kimryn Rathmell, MD, PhD, director of the Division of Hematology and Oncology at Vanderbilt University Medical Center in Nashville, has twice been awarded grants by the American Association for Cancer Research (AACR). “The AACR does a great job of identifying high-risk, high-reward research,” Dr. Rathmell said.
A renowned authority on hormones and their role in disease, Dr. Evans has conducted research that has led to the discovery of nearly 50 nuclear hormone receptors.
For Michael A. Caligiuri, MD, the 2017-2018 AACR President, it is unacceptable that advances in cancer care and treatment don’t benefit everyone equally. Dr. Caligiuri made cancer health disparities one of the signature issues of his tenure as AACR President.
Dr. Horwitz's contributions to the field encompass agents that have served as prototypes for some of the most important drugs currently in clinical use. Her most seminal contribution has been in the development of Taxol®, a drug isolated from the yew plant, Taxus brevifolia.
Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
James P. Allison, PhD: Untangling the complexities of the immune system to pioneer cancer immunotherapy.
Elaine R. Mardis, PhD, spends a lot of her time studying molecules at the Institute for Genomic Medicine at Nationwide Children’s Hospital in Columbus, Ohio. What she sees is invisible to the naked eye, but her vision for what clinicians can do with the information they find in the genes of a cancer cell is clear.
Fellow of the AACR Academy John E. Dick, PhD, earns the 2020 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research.
A leader in the study of how mutations affecting tumor-suppressor genes cause cancer, Dr. Kaelin's research has had major clinical implications for several forms of cancer, particularly kidney cancer. Dr. Kaelin, Sir Peter J. Ratcliffe, MD, FRS, and Gregg L. Semenza, MD, PhD, were awarded the 2019 Nobel Prize in Physiology or Medicine.
American Association for Cancer Research 2017-2018 President Elizabeth M. Jaffee, MD, seeks ways to expand AACR's efforts to nurture the next generation of cancer researchers and advance convergence science during her term leading the organization.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now